Advertisement

What everyone must know about ovarian cancer

Learn about the symptoms, risk factors, prognosis, and more.

Updated on September 17, 2025

Each year, more than 12,000 women in the United States die of ovarian cancer. If treated early, before the cancer has spread, the five-year survival rate is over 90 percent. But survival rates drop steeply as the disease progresses.

With that in mind, here are the five things to know about ovarian cancer.

Symptoms tend to whisper

Ovarian cancer is difficult to detect in its early stages because there frequently aren’t symptoms. When there are symptoms, such as bloating or diarrhea, they may be easily overlooked or attributed to other issues. That said, signs of the condition include:

  • Abdominal swelling
  • Belly or pelvic pain
  • Difficulty eating
  • Feeling full quickly
  • Having to urinate often or very suddenly
  • Bowel habit changes
  • Vaginal bleeding, particularly after menopause

In the course of a month, if you have any of these symptoms more than 12 times, see a healthcare provider (HCP).

Certain factors increase your risk

The biggest risk factor for ovarian cancer is family history. Having a first-degree relative (a sister, your mother) with the disease greatly increases your chances of developing it. Genetic mutations play a role, too. For example, people who inherit a harmful BRCA1 (BReast CAncer gene 1) variant have up to a 44 percent chance of developing ovarian cancer by ages 70 to 80, according to the National Cancer Institute (NCI). Up to 17 percent of those with a BRCA2 mutation will develop the disease. People with hereditary nonpolyposis colorectal cancer (Lynch syndrome) are also at higher risk.

But that only accounts for a small minority of cases. Ovarian cancer doesn’t run in the family for most people with the illness. Other factors increasing your risk include:

  • Your age—about 88 percent of cases occur in those ages 45 and older
  • Having never carried a baby to full term
  • Having a baby for the first time after age 35
  • Being overweight or obese
  • Having endometriosis, a condition in which tissue similar to uterine lining grows outside of the uterus, usually elsewhere in the pelvis

Some studies suggest there may be a link between ovarian cancer risk and using hormone replacement therapy (HRT) in certain cases. The risk may gradually decrease once HRT is discontinued.

Other factors can lower your risk

Using birth control pills (specifically for premenopausal women) is one step you can take to help reduce the risk of ovarian cancer. Whether or not you have a family history of breast or ovarian cancer, taking birth control pills for at least five years (not necessarily consecutively) may cut your chances up to 50 percent.

Pregnancy and breastfeeding have also been shown to lower risk. So does undergoing tubal ligation, when the fallopian tubes are tied to prevent pregnancy. Depending on your individual medical situation, having a hysterectomy (removal of the uterus), a salpingectomy (removal of the fallopian tubes), or a salpingo-oophorectomy (removal of the ovaries and fallopian tubes) can reduce your risk, as well. Research suggests salpingectomy is significantly more effective than tubal ligation for lowering risk.

All of these factors cut the number of times a person ovulates, and research shows the risk of ovarian cancer decreases when you ovulate less.

Screening may not be a good option yet

There is no reliable ovarian cancer screening. The United States Preventive Service Task Force (USPSTF) is an group of independent experts who make recommendations for health care and disease prevention. After analyzing multiple studies of people screened for the disease, the USPSTF concluded ovarian screening tests do more harm than good because they lead to too many false positives.

When the disease is suspected, an HCP may order a transvaginal ultrasound and a blood test for cancer marker CA-125. These tests are typically reserved for people considered to be at high risk. This is why it’s so important to pay attention to potential warning signs.

Ovarian cancer is not a death sentence

Once you have symptoms or are diagnosed with ovarian cancer, it’s not too late. There are several ways to treat the disease depending on the type of cancer you have and how far it has spread. Treatments include chemotherapy, immunotherapy, targeted therapy, hormone therapy, surgery, and radiation therapy, or a combination of multiple treatments. Talk to an HCP about the options available to you, as well as the benefits and side effects.

Article sources open article sources

National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Cancer Facts: Common Cancer Sites. Accessed September 2025.
Siegel RL, Giaquinto AN, et al. Cancer statistics, 2024. CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49.
Siegel RL, Miller KD, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023 Jan;73(1):17-48.
American Cancer Society. Survival Rates for Ovarian Cancer. August 8, 2025.
American Cancer Society. Ovarian Cancer Early Detection, Diagnosis, and Staging. August 8, 2025.
National Cancer Institute. Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Screening (PDQ)–Patient Version. February 12, 2025.
Centers for Disease Control and Prevention. Hereditary Breast and Ovarian Cancer: People at Increased Risk for BRCA Gene Mutations. September 3, 2024.
National Cancer Institute. BRCA Gene Mutations: Cancer Risk and Genetic Testing. Reviewed July 10, 2024.
Penn Medicine Abramson Cancer Center. Risk Factors for Ovarian Cancer. Accessed September 15, 2025.
World Health Organization. Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study. February 23, 2023.
American Cancer Society. Menopausal Hormone Therapy and Cancer Risk. February 13, 2015
Xiang H, Wang L, et al. The risk of ovarian cancer in hormone replacement therapy users: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024 Jul 17;15:1414968.
American Cancer Society. Ovarian Cancer Risk Factors. August 25, 2025.
National Cancer Institute. Oral Contraceptives and Cancer Risk. Reviewed February 22, 2018.
Duus AH, Zheng G, et al. Risk of ovarian cancer after salpingectomy and tubal ligation: Prospects on histology and time since the procedure. Gynecol Oncol. 2023 Oct;177:125-131.
U.S. Preventive Services Task Force. Ovarian Cancer: Screening. February 13, 2018.
Mayo Clinic. Ovarian cancer. May 2, 2025.
American Cancer Society. Treating Ovarian Cancer. August 8, 2025.
The role of the obstetrician–gynecologist in the early detection of epithelial ovarian cancer in women at average risk. Committee Opinion No. 716. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e146–9.

Featured Content

video

How is ovarian cancer diagnosed and treated?

A mass on the ovary is usually detected through transvaginal ultrasound, but needs further testing before diagnosis.
article

I have a BRCA gene mutation. Should I be worried?

The BRCA gene mutations raise a person's breast and ovarian cancer risk.